ACCREDITATION STATEMENT
Focal Therapy
2024 FOCAL+ Annual Meeting
October 17 – 19, 2024
San Diego, CA
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
Insupport of improving patient care, this activity has been planned and implemented by Amedco LLC and Focal Therapy (FT). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 20.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians
Amedco LLC designates this enduring material for a maximum of 18.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Objectives – After Attending This Program You Should Be Able To
- Describe the rationale, the latest evidence on oncological and functional outcomes, surveillance strategies and management of the complications of focal therapy.
- Describe the indications, preoperative evaluation, surgical steps/procedure, and expected patient outcomes for various minimally invasive operations for BPH.
- Describe guideline concordant management of metastatic prostate cancer.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
|
First |
Last |
Commercial Interest |
|
Andre |
Abreu |
Koelis:Research Grant Site Principal Investigator,EDAP:Speakers Bureau,Sonablate:Consultant |
|
Mohammadmehdi |
Adhami |
NA |
|
Julien |
Anract |
Koelis:Consultant |
|
Aaron |
Berger |
Johnson and Johnson:Speakers Bureau,Astellas:Speakers Bureau,Bayer:Speakers Bureau,Pfizer:Speakers Bureau,Accord BioPharma:Speakers Bureau,Sumitomo:Speakers Bureau,Cleveland Diagnostics:Consultant,Bioprotect:Consultant |
|
Giovanni |
Cacciamani |
NA |
|
Bilal |
Chughtai |
NA |
|
Ralph |
Clayman |
Applied Medical:Stock Shareholder,Verve Inc.:Consultant,IPG :Research Grant Site Principal Investigator |
|
John Michael |
DiBianco |
Boston Scientific:Consultant,Richard Wolf:Consultant |
|
Jonathan |
Fainberg |
Koelis:Consultant,Angiodynamics:Consultant |
|
Arvin |
George |
Nanospectra Biosciences:Research Grant Site Principal Investigator,Angiodynamics:Research Grant Overall Principal Investigator,Francis Medical :Research Grant Overall Principal Investigator,Sonablate Corporation:Consultant,HIFU Prostate Services:Consultant,CIVCO:Consultant,BK Medical:Consultant,Lina Med:Consultant,Boston Scientific:Consultant |
|
A |
Herati |
Teleflex :Consultant,Olympus:Consultant |
|
Juan |
Javier-Desloges |
NA |
|
Veeru |
Kasivisvanathan |
NA |
|
Aaron |
katz |
NA |
|
Amir |
Lebastchi |
Koelis Trinity:Consultant,Edap FocalOne:Consultant,Johnson and Johnson:Research Grant Site Principal Investigator,Telix Pharmaceuticles:Consultant |
|
Herbert |
Lepor |
Provepharm:Consultant,Urogen:Public Stock Shareholder,BlueEarth:Research Grant Site Principal Investigator |
|
Stacy |
Loeb |
Astellas:Consultant |
|
Derek |
Lomas |
NA |
|
Rana |
McKay |
Ambrx, Arcus, AstraZeneca, AVEO Pharmaceuticals, Bayer, Blue Earth Diagnostics, Bristol Myers Squibb, Calithera, Caris, Dendreon, Eisai, Eli Lilly, Exelixis, Janssen, Merck, MOMA, Myovant, Novartis:Scientific/Medical Advisory Board Member,NeoMorph, Pfizer, Sanofi, Seagen, Sorrento Therapeutics, Telix, and Tempus:Scientific/Medical Advisory Board Member |
|
Xiaosong |
Meng |
Angiodynamics, Profound Medical:Research Grant Site Principal Investigator,EDAP, Profound Medical:Consultant |
|
Nicole |
Miller |
Boston Scientific:Consultant,Karl Storz Endoscopy:Research Grant Site Principal Investigator,Virtuoso Surgical:Consultant |
|
Ruben |
Olivares |
Edap:Consultant |
|
Peter |
Pinto |
Philips:Patent Holder |
|
Alan |
Priester |
Avenda Health:Employee |
|
Arun |
Rai |
Hatchleaf Inc.:Owner,Activ Surgical:Consultant |
|
Natalie |
Reizine |
AstraZeneca:Speakers Bureau,Janssen:Speakers Bureau,Merck:Speakers Bureau |
|
Michael |
Rothberg |
NA |
|
steven |
rowe |
Lantheus:Speakers Bureau,Telix:Consultant,Blue Earth:Consultant,Imaging Endpoints:Consultant,Precision Molecular:Public Stock Shareholder |
|
Tracy |
Sandstrom |
NA |
|
Abhinav |
Sidana |
Janssen Oncology:Speakers Bureau,Myovant:Scientific/Medical Advisory Board Member,Astellas:Scientific/Medical Advisory Board Member,Pfizer:Scientific/Medical Advisory Board Member,Bayer:Scientific/Medical Advisory Board Member,Curio:Consultant,Sonablate:Consultant,Astrazeneca:Speakers Bureau,Hifu Prostate Services:Consultant |
|
Ilya |
Sobol |
Storz :Consultant,Ambu :Consultant |
|
Daniel |
Song |
BioProtect:Research Grant Site Principal Investigator,Candela:Research Grant Site Principal Investigator,Lantheus:Consultant,Bayer:Research Grant Site Principal Investigator |
|
Preston |
Sprenkle |
Profound Medical:Scientific/Medical Advisory Board Member,Telix Pharmacueticals:Scientific/Medical Advisory Board Member,Boston Scientific:Consultant |
|
Alan |
Tan |
bristol myers squibb:Speakers Bureau,exelixis:Consultant,emd serono:Speakers Bureau,Pfizer:Consultant,gilead:Consultant |
|
Baris |
Turkbey |
NVIDIA:Other,Philips:Other |
|
sadhna |
verma |
NA |
|
Karla |
Witzke |
Olympus:Speakers Bureau |
|
Richard |
Wu |
NA |
|
James |
Wysock |
Focal One:Consultant,ExoDx:Speakers Bureau |
|
Kevin |
Zorn |
Boston Scientific:Scientific/Medical Advisory Board Member,Procept Biorobotics:Scientific/Medical Advisory Board Member,Zenflow:Research Grant Site Principal Investigator,Clarius:Scientific/Medical Advisory Board Member |